Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to ritlecitinib with or without narrow-band UVB add-on therapy in patients with active nonsegmental vitiligo: results from a phase 2b extension study.
Yamaguchi Y, Peeva E, Adiri R, Ghosh P, Napatalung L, Hamzavi I, Pandya AG, Shore RN, Ezzedine K, Guttman-Yassky E. Yamaguchi Y, et al. Among authors: ezzedine k. J Am Acad Dermatol. 2024 Dec 19:S0190-9622(24)03381-4. doi: 10.1016/j.jaad.2024.11.064. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39709084
Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
Simpson E, Fernández-Peñas P, de Bruin-Weller M, Lio PA, Chu CY, Ezzedine K, Agell H, Casillas M, Ding Y, Yang FE, Pierce E, Bieber T. Simpson E, et al. Among authors: ezzedine k. Adv Ther. 2024 Dec 5. doi: 10.1007/s12325-024-03010-9. Online ahead of print. Adv Ther. 2024. PMID: 39636571 No abstract available.
Ultraprocessed Food Intake and Psoriasis.
Penso L, Touvier M, Srour B, Ezzedine K, Sbidian E. Penso L, et al. Among authors: ezzedine k. JAMA Dermatol. 2024 Nov 27. doi: 10.1001/jamadermatol.2024.4832. Online ahead of print. JAMA Dermatol. 2024. PMID: 39602129
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
Simpson E, Fernández-Peñas P, de Bruin-Weller M, Lio PA, Chu CY, Ezzedine K, Agell H, Casillas M, Ding Y, Yang FE, Pierce E, Bieber T. Simpson E, et al. Among authors: ezzedine k. Adv Ther. 2024 Sep 9. doi: 10.1007/s12325-024-02974-y. Online ahead of print. Adv Ther. 2024. PMID: 39249591
Sexuality impairment in patients with atopic dermatitis.
Misery L, Seneschal J, Corgibet F, Halioua B, Sampogna F, Merhand S, Skayem C, Hayoun YB, Taieb C, Staumont-Sallé D, Ezzedine K, Richard MA. Misery L, et al. Among authors: ezzedine k. Clin Exp Dermatol. 2024 Sep 4:llae360. doi: 10.1093/ced/llae360. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 39229930 No abstract available.
Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema-Findings from the Danish Skin Cohort.
Christensen MO, Sieborg J, Nymand LK, Guttman-Yassky E, Ezzedine K, Schlapbach C, Molin S, Zhang J, Zachariae C, Thomsen SF, Thyssen JP, Egeberg A. Christensen MO, et al. Among authors: ezzedine k. J Am Acad Dermatol. 2024 Dec;91(6):1094-1103. doi: 10.1016/j.jaad.2024.07.1503. Epub 2024 Aug 22. J Am Acad Dermatol. 2024. PMID: 39181406 Free article.
The atopic dermatitis patient journey: insights from a qualitative study.
Kpenou FC, Paul C, Seneschal J, Andreu N, Barbarot S, Tauber M, Natella PA, Shourick J, Ezzedine K. Kpenou FC, et al. Among authors: ezzedine k. Br J Dermatol. 2024 Dec 23;192(1):162-163. doi: 10.1093/bjd/ljae329. Br J Dermatol. 2024. PMID: 39154353 No abstract available.
363 results